Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Trojano

Showing results (151-160 of 342) with videos related to

Pageof 35
Sort By:
Plos One|July 9, 2016
The Cost of Relapsing-Remitting Multiple Sclerosis Patients Who Develop Neutralizing Antibodies during Interferon Beta TherapyDamiano Paolicelli, Sergio Iannazzo, Laura Santoni, et al.
Frontiers in Neurology|May 10, 2021
Multicenter Interventional Phase IV Study for the Assessment of the Effects on Patient's Satisfaction of Peg IFN Beta-1a (Pre-filled Pen) in Subjects With Relapsing-Remitting Multiple Sclerosis Unsatisfied With Other Injectable Subcutaneous Interferons (PLATINUM Study)Diego Centonze, Roberta Fantozzi, Fabio Buttari, et al.
Neuroimmunomodulation|April 5, 2012
Dopaminergic modulation of CD4+CD25(high) regulatory T lymphocytes in multiple sclerosis patients during interferon-β therapyMarco Cosentino, Mauro Zaffaroni, Maria Trojano, et al.
Current Neurovascular Research|April 6, 2012
Multigate quality Doppler profiles and morphological/hemodynamic alterations in multiple sclerosis patientsMarco Matteo Ciccone, Aldo Innocente Galeandro, Pietro Scicchitano, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 26, 2021
Early treatment delays long-term disability accrual in RRMS: Results from the BMSD networkPietro Iaffaldano, Giuseppe Lucisano, Helmut Butzkueven, et al.
Journal of Neurology|March 3, 2004
Association between Synapsin III gene promoter polymorphisms and multiple sclerosisMaria Liguori, Rita Cittadella, Ida Manna, et al.
Brain Sciences|December 23, 2022
Real-Life Experience of the Effects of Cladribine Tablets on Lymphocyte Subsets and Serum Neurofilament Light Chain Levels in Relapsing Multiple Sclerosis PatientsDamiano Paolicelli, Maddalena Ruggieri, Alessia Manni, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 1, 2019
Correction to: The Italian multiple sclerosis registerMaria Trojano, Roberto Bergamaschi, Maria Pia Amato, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 15, 2018
The Italian multiple sclerosis registerMaria Trojano, Roberto Bergamaschi, Maria Pia Amato, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 2, 2012
Immunomodulatory therapies delay disease progression in multiple sclerosisRoberto Bergamaschi, Silvana Quaglini, Eleonora Tavazzi, et al.
Pageof 35

Showing results (151-160 of 342) with videos related to

Sort By:
Pageof 35
Plos One|July 9, 2016
The Cost of Relapsing-Remitting Multiple Sclerosis Patients Who Develop Neutralizing Antibodies during Interferon Beta TherapyDamiano Paolicelli, Sergio Iannazzo, Laura Santoni, et al.
Frontiers in Neurology|May 10, 2021
Multicenter Interventional Phase IV Study for the Assessment of the Effects on Patient's Satisfaction of Peg IFN Beta-1a (Pre-filled Pen) in Subjects With Relapsing-Remitting Multiple Sclerosis Unsatisfied With Other Injectable Subcutaneous Interferons (PLATINUM Study)Diego Centonze, Roberta Fantozzi, Fabio Buttari, et al.
Neuroimmunomodulation|April 5, 2012
Dopaminergic modulation of CD4+CD25(high) regulatory T lymphocytes in multiple sclerosis patients during interferon-β therapyMarco Cosentino, Mauro Zaffaroni, Maria Trojano, et al.
Current Neurovascular Research|April 6, 2012
Multigate quality Doppler profiles and morphological/hemodynamic alterations in multiple sclerosis patientsMarco Matteo Ciccone, Aldo Innocente Galeandro, Pietro Scicchitano, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 26, 2021
Early treatment delays long-term disability accrual in RRMS: Results from the BMSD networkPietro Iaffaldano, Giuseppe Lucisano, Helmut Butzkueven, et al.
Journal of Neurology|March 3, 2004
Association between Synapsin III gene promoter polymorphisms and multiple sclerosisMaria Liguori, Rita Cittadella, Ida Manna, et al.
Brain Sciences|December 23, 2022
Real-Life Experience of the Effects of Cladribine Tablets on Lymphocyte Subsets and Serum Neurofilament Light Chain Levels in Relapsing Multiple Sclerosis PatientsDamiano Paolicelli, Maddalena Ruggieri, Alessia Manni, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 1, 2019
Correction to: The Italian multiple sclerosis registerMaria Trojano, Roberto Bergamaschi, Maria Pia Amato, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 15, 2018
The Italian multiple sclerosis registerMaria Trojano, Roberto Bergamaschi, Maria Pia Amato, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 2, 2012
Immunomodulatory therapies delay disease progression in multiple sclerosisRoberto Bergamaschi, Silvana Quaglini, Eleonora Tavazzi, et al.
Pageof 35